LIF AMP, Adjustable Awl, REF 117-165, Part of the AMP System. Used with Spine Lateral Interbody S...

FDA Device Recall #Z-2475-2023 — Class II — July 7, 2023

Recall Summary

Recall Number Z-2475-2023
Classification Class II — Moderate risk
Date Initiated July 7, 2023
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Alphatec Spine, Inc.
Location Carlsbad, CA
Product Type Devices
Quantity 29

Product Description

LIF AMP, Adjustable Awl, REF 117-165, Part of the AMP System. Used with Spine Lateral Interbody Systems, IdentiTi LIF, Transcend LIF and Battalion LLIF,

Reason for Recall

Awl instrument adjustable drill button assembly assembled in the incorrect orientation, preventing locking feature from engaging with shaft at the desired set point; instruments lack ability to control awl depth by means of adjustable shaft advancement stop, which may lead to over insertion, dural tear, vascular/neurologic injury, adjacent tissue damage, increased operative time, revision surgery.

Distribution Pattern

US Nationwide distribution in the states of CT, IN, TX, LA, OH, AL, NH, MA, NC, AZ, MD, NJ, IL, CA, UT, MI.

Lot / Code Information

UDI-DI: 00190376228037, Lot: EM50715

Other Recalls from Alphatec Spine, Inc.

Recall # Classification Product Date
Z-1343-2026 Class II ATEC Lateral Navigation Disc Prep Instruments ... Jan 2, 2026
Z-1342-2026 Class II ATEC Lateral Navigation Disc Prep Instruments ... Jan 2, 2026
Z-1065-2025 Class II Calibrate CCX Interbody System for spinal fusio... Dec 15, 2024
Z-1182-2024 Class II IdentiTi ALIF Standalone Interbody System: Par... Jan 26, 2024
Z-0196-2023 Class II Disc Preparation instruments contained in the f... Sep 14, 2022

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.